Evidence map›Paper›PMID 36277202›Full record

ArticleFrontiers in physiology2022

Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies.

Alice Main, Andri Boguslavskyi, Jacqueline Howie, Chien-Wen Kuo, Aileen Rankin, Francis L Burton, Godfrey L Smith, Roger Hajjar, George S Baillie, Kenneth S Campbell and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Alice MainInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Andri BoguslavskyiSchool of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, United Kingdom.
Jacqueline HowieInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Chien-Wen KuoInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Aileen RankinInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Francis L BurtonInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Godfrey L SmithInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Roger HajjarFlagship Pioneering, Cambridge, MA, United States.
George S BaillieInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Kenneth S CampbellDivision of Cardiovascular Medicine, University of Kentucky, Lexington, KY, United States.
Michael J ShattockSchool of Cardiovascular and Metabolic Medicine and Sciences, King's College London, London, United Kingdom.
William FullerInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
University of Glasgow · GBKing's College London · GBFlagship Pioneering (United States) · USUniversity of Kentucky · US

Funding

Dual filament control of myocardial power and hemodynamicsR01HL148785 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI Kenneth S Campbell, Thomas Kampourakis · 2020 to 2026
$3.2M
Length-dependent activation in human myocardiumR01HL149164 · NHLBI · UNIVERSITY OF KENTUCKY · PI CAMPBELL, KENNETH S, TANNER, BERTRAND C.W. · 2020 to 2023
$2.8M
British Heart Foundation PG/17/26/32881British Heart Foundation PG/18/60/33957British Heart Foundation RG/17/15/33106NHLBI NIH HHS R01 HL148785
6 · The paper itself

Abstract

S-palmitoylation is an essential lipid modification catalysed by zDHHC-palmitoyl acyltransferases that regulates the localisation and activity of substrates in every class of protein and tissue investigated to date. In the heart, S-palmitoylation regulates sodium-calcium exchanger (NCX1) inactivation, phospholemman (PLM) inhibition of the Na

Indexed as

cardiac muscledepalmitoylationheart failurehypertrophyion transporterpalmitoylationZDHHC5

Identifiers

PMID36277202
PMCPMC9581287
OpenAlexW4301586621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.